NCTY [The9] 6-K: (Original Filing)

[THE9 LIMITED Jun Zhu Chairman and Chief Executive Officer The9 Limited Announces Receipt of Nasdaq Notice of Deficiency The Company’s management is looking into various options available to regain compliance and maintain its continued listing on The NASDAQ Global Market, and is also considering othe]

By | 2017-02-24T16:11:37+00:00 February 24th, 2017|Categories: Chinese Stocks, NCTY, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: China Cord Blood Corporation Reports Financial Results for

[China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2017 3Q17 Added 19,712 New Subscribers 3Q17 Revenue Up 18.6% YOY to RMB200.9 Million ($28.9 Million) 3Q17 Operating Income Reached RMB101.7 Million ($14.6 Million) Conference Call to be Held ]

By | 2017-02-25T03:22:12+00:00 February 24th, 2017|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

NCTY [The9] 6-K: THE9 LIMITED Jun Zhu Chairman and Chief Executive

[THE9 LIMITED Jun Zhu Chairman and Chief Executive Officer The9 Limited Announces Receipt of Nasdaq Notice of Deficiency The Company’s management is looking into various options available to regain compliance and maintain its continued listing on The NASDAQ Global Market, and is also considering othe]

By | 2017-02-24T16:12:02+00:00 February 24th, 2017|Categories: Chinese Stocks, NCTY, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals] 8-K: (Original Filing)

[FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): February 21, 2017 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Provinc]

By | 2017-02-25T03:23:39+00:00 February 24th, 2017|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

SINA [SINA] 6-K: (Original Filing)

[SINA Reports Fourth Quarter and Fiscal Year 2016 Financial Results SHANGHAI, China—February 22, 2017— Fourth Quarter 2016 Highlights · · · · · · Fiscal Year 2016 Highlights · · · · · “We closed a great year of 2016 with another strong quarter. Our full year revenue exceeded $1 billion, representing ]

By | 2017-02-24T16:12:42+00:00 February 24th, 2017|Categories: Chinese Stocks, SEC Original, SINA|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals] 8-K: FORM 8-K CURRENT REPORT Date of Report (Date

[FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): February 21, 2017 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Provinc]

By | 2017-02-25T03:24:01+00:00 February 24th, 2017|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

SINA [SINA] 6-K: SINA Reports Fourth Quarter and Fiscal Year 2016

[SINA Reports Fourth Quarter and Fiscal Year 2016 Financial Results SHANGHAI, China—February 22, 2017— Fourth Quarter 2016 Highlights · · · · · · Fiscal Year 2016 Highlights · · · · · “We closed a great year of 2016 with another strong quarter. Our full year revenue exceeded $1 billion, representing ]

By | 2017-02-24T16:13:04+00:00 February 24th, 2017|Categories: Chinese Stocks, SINA, Webplus ver|Tags: , , , , , |0 Comments

BIDU [Baidu] 6-K: (Original Filing)

[Baidu Announces Fourth Quarter and Fiscal Year 2016 Results 1 BEIJING, China, February 23, 2017 – Baidu, Inc. (NASDAQ: BIDU) (“Baidu” or the “Company”), the leading Chinese language Internet search provider, today announced its unaudited financial results for the fourth quarter and fiscal year ended]

Skip to toolbar